{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:16:37Z","timestamp":1790975797748,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies about perimenopausal migraine are limited. In this study, we aimed to explore the characteristics of perimenopausal migraine and to compare perimenopausal women with and without migraine in terms of the levels of Estradiol and Follicle-Stimulating Hormone (FSH). We also aimed to correlate migraine severity scores with Estradiol and FSH levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A case-control study of 66 subjects divided as Group 1 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922): migraine onset during perimenopause, Group 2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922) migraine onset before perimenopause, and Group 3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922) age-matched healthy controls. Perimenopausal women with any type of migraine (age 40\u201355 years) were eligible. We excluded secondary and other primary headaches, hormonal therapy and chronic illness. Subjects underwent a detailed history taking of headache and vasomotor symptoms, MIDAS and VAS scores. Measurement of Estradiol (E2) and FSH levels was done for all participants. Comparisons were done between group 1 and group 2 by migraine characteristics, vasomotor symptoms and Estradiol and FSH levels. Group 3 (control) was compared with both migraine groups 1 and 2 by vasomotor symptoms and Estradiol and FSH levels. Statistical analysis was performed by using SPSS 27th edition Statistical tests used include mean, median, count, Mann-Whitney U, Kruskal-Wallis test, Chi-squared test and the Spearman correlation test (The suitable test was chosen based on the type of variables and data, and the number of comparison groups).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Migraine with onset during perimenopause was characterized by throbbing pain, alternating laterality, orbito-fronto-temporal site, moderate to severe intensity, high frequency, with associated phonophobia and photophobia, while autonomic symptoms were rare. There was analgesic overuse and an unsatisfactory response. Group 2 significantly had more postdrome symptoms, less analgesic response and more menstrually-triggered migraine than Group 1 (P &lt; 0.05). Both perimenopausal migraine groups (Group 1 and 2) had significantly more perimenopausal symptoms, including fatigue, sleep disturbance, mood symptoms and anxiety (P &lt; 0.05) compared to the control (Group 3). Hot flashes, night sweating and vaginal dryness were more common in migraineurs without statistical significance. Migraineurs had significantly lower Estradiol levels and a higher proportion of subjects with Estradiol\u2009&lt;\u200950 pg.\/ml than controls (P &lt; 0.05). There was a significant negative correlation between Estradiol and scores, including MIDAS (Rho=-0.406,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007) and VAS (Rho= -0.331,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.030). No difference in the FSH levels among the Groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Perimenopause is associated with high-frequency, moderate to severe migraine headache. Lower Estradiol levels were correlated with high migraine severity scores (VAS and MIDAS). The frequency of perimenopausal symptoms is higher, whereas the Estradiol level is lower in migrainous compared to nonmigrainous women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-026-02418-8","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:13:55Z","timestamp":1781608435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics of perimenopausal migraine and its correlation to hormonal levels"],"prefix":"10.1186","volume":"27","author":[{"given":"Lobna Talaat","family":"El-Ghoneimy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nervana M.","family":"Elfayoumy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menatallah Mohamed Saleh","family":"Elaguizy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anter Mothenna Abdullah","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Abdelghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2418_CR1","doi-asserted-by":"publisher","unstructured":"MacGregor EA (2020) Menstrual and perimenopausal migraine: a narrative review, Maturitas. 142;24\u201330. https:\/\/doi.org\/10.1016\/j.maturitas.2020.07.005.","DOI":"10.1016\/j.maturitas.2020.07.005"},{"issue":"2","key":"2418_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41582-022-00763-1","volume":"19","author":"TJ Steiner","year":"2023","unstructured":"Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19(2):109\u2013117. https:\/\/doi.org\/10.1038\/s41582-022-00763-1","journal-title":"Nat Rev Neurol"},{"key":"2418_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s10194-015-0569-6","volume":"16","author":"NA El-Sherbiny","year":"2015","unstructured":"El-Sherbiny NA, Masoud M, Shalaby NM, Shehata HS (2015) Prevalence of primary headache disorders in Fayoum Governorate, Egypt. J Headache Pain 16:85. https:\/\/doi.org\/10.1186\/s10194-015-0569-6","journal-title":"J Headache Pain"},{"key":"2418_CR4","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2147\/NDT.S42392","volume":"9","author":"H El-Tallawy","year":"2013","unstructured":"El-Tallawy H et al (2013) Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects. Neuropsychiatr Dis Treat 9:1295\u20131300. https:\/\/doi.org\/10.2147\/NDT.S42392","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2418_CR5","doi-asserted-by":"crossref","unstructured":"Degan D, Tiseo C, Stewart J, Pistoia F, Carolei A, Sacco S (2015) Migraine in menopausal women: a systematic review, pp. 773\u2013782","DOI":"10.2147\/IJWH.S70073"},{"key":"2418_CR6","doi-asserted-by":"publisher","unstructured":"Ibrahimi K, Couturier EGM, Maassenvandenbrink A (2014) Migraine and perimenopause. Maturitas. 1\u20134. https:\/\/doi.org\/10.1016\/j.maturitas.2014.05.018","DOI":"10.1016\/j.maturitas.2014.05.018"},{"issue":"4","key":"2418_CR7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/head.13291","volume":"58","author":"H Calhoun","year":"2018","unstructured":"Calhoun H, Migraine UM (2018) Headache 58(4):626\u2013630. https:\/\/doi.org\/10.1111\/head.13291","journal-title":"Headache"},{"key":"2418_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13697137.2018.1439914","volume":"0","author":"MAH Rodrigues","year":"2018","unstructured":"Rodrigues MAH, Gompel A, Rodrigues MAH (2018) Migraine, hormones and the menopausal transition. Climacteric 0:1\u201311. https:\/\/doi.org\/10.1080\/13697137.2018.1439914","journal-title":"Climacteric"},{"key":"2418_CR9","doi-asserted-by":"publisher","unstructured":"Oh K, Choi KJJ, Park WSK (2012) Headaches in middle-aged women during menopausal transition: a headache clinic-based study. 705:79\u201383. https:\/\/doi.org\/10.1159\/000336838.","DOI":"10.1159\/000336838"},{"key":"2418_CR10","doi-asserted-by":"publisher","unstructured":"Tang B, Yu X, Jiang W, Zhang C, Zhan T, He Y (May 2021) Clinical significance of serum sex hormones in postmenopausal women with vestibular migraine: potential role of estradiol. J Int Med Res. 49(5):3000605211016379. https:\/\/doi.org\/10.1177\/03000605211016379","DOI":"10.1177\/03000605211016379"},{"key":"2418_CR11","doi-asserted-by":"publisher","unstructured":"Harlow D et al (2012) Aging workshop 10: addressing the unfinished agenda of staging reproductive aging. 97;1159\u20131168. https:\/\/doi.org\/10.1210\/jc.2011-3362","DOI":"10.1210\/jc.2011-3362"},{"key":"2418_CR12","doi-asserted-by":"publisher","unstructured":"Davies M, Sarri G, Lumsden MA (2017) Diagnosis of the menopause: NICE guidance and quality standards., Ann. Clin. Biochem. 54(5):516\u2013518. https:\/\/doi.org\/10.1177\/0004563217706381","DOI":"10.1177\/0004563217706381"},{"key":"2418_CR13","doi-asserted-by":"publisher","unstructured":"Olesen J, Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition, Cephalalgia 38(1): 1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"issue":"3","key":"2418_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1212\/WNL.0000000000006697","volume":"92","author":"TP Do","year":"2019","unstructured":"Do TP et al (2019) Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology 92(3):134\u2013144. https:\/\/doi.org\/10.1212\/WNL.0000000000006697","journal-title":"Neurology"},{"key":"2418_CR15","doi-asserted-by":"publisher","unstructured":"Stewart WF, Lipton RB, Kolodner K (2003) Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms., Headache 43(3): 258\u2013265https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03050.x","DOI":"10.1046\/j.1526-4610.2003.03050.x"},{"issue":"7","key":"2418_CR16","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","volume":"14","author":"B Williamson","year":"2005","unstructured":"Williamson B, Hoggart (2005) Pain: A review of three commonly used pain rating scales. J Clin Nurs 14(7):798\u2013804. https:\/\/doi.org\/10.1111\/j.1365-2702.2005.01121.x","journal-title":"J Clin Nurs"},{"key":"2418_CR17","doi-asserted-by":"publisher","unstructured":"Martin VT, Pavlovic J, Fanning KM, Buse DC, Reed ML, Lipton RB (2016) Perimenopause and menopause are associated with high the american migraine prevalence and prevention study. 292\u2013305. https:\/\/doi.org\/10.1111\/head.12763","DOI":"10.1111\/head.12763"},{"issue":"9","key":"2418_CR18","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/head.13407","volume":"58","author":"RB Lipton","year":"2018","unstructured":"Lipton RB et al (2018) Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Headache 58(9):1408\u20131426. https:\/\/doi.org\/10.1111\/head.13407","journal-title":"Headache"},{"key":"2418_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fneur.2020.00140","volume":"11","author":"N Karsan","year":"2020","unstructured":"Karsan N, Goadsby PJ (2020) Imaging the Premonitory Phase of Migraine. Front Neurol 11:140. https:\/\/doi.org\/10.3389\/fneur.2020.00140","journal-title":"Front Neurol"},{"issue":"9","key":"2418_CR20","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/ene.12451","volume":"21","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Schankin C, Goadsby PJ (2014) Photic hypersensitivity in the premonitory phase of migraine - a positron emission tomography study. Eur J Neurol 21(9):1178\u20131183. https:\/\/doi.org\/10.1111\/ene.12451","journal-title":"Eur J Neurol"},{"key":"2418_CR21","doi-asserted-by":"publisher","unstructured":"Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD (2006) The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients., Cephalalgia 26(10);1209\u20131213. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01195.x","DOI":"10.1111\/j.1468-2982.2006.01195.x"},{"issue":"3","key":"2418_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1547-5069.2006.00114.x","volume":"38","author":"MF Moloney","year":"2006","unstructured":"Moloney MF, Strickland OL, DeRossett SE, Melby MK, Dietrich AS (2006) The experiences of midlife women with migraines. J Nurs Scholarsh 38(3):278\u2013285. https:\/\/doi.org\/10.1111\/j.1547-5069.2006.00114.x","journal-title":"J Nurs Scholarsh"},{"key":"2418_CR23","doi-asserted-by":"publisher","unstructured":"Li W, Diao X, Chen C, Li C, Zhang Y, Li Y (Apr. 2018) Changes in hormones of the hypothalamic-pituitary-gonadal axis in migraine patients. J Clin Neurosci Off J Neurosurg Soc Australas 50:165\u2013171. https:\/\/doi.org\/10.1016\/j.jocn.2017.11.011","DOI":"10.1016\/j.jocn.2017.11.011"},{"key":"2418_CR24","doi-asserted-by":"publisher","unstructured":"Lipton RB et al (2018) Migraine in america symptoms and treatment (MAST) study: baseline study methods, treatment patterns, and gender differences., headache 58(9);1408\u20131426. https:\/\/doi.org\/10.1111\/head.13407","DOI":"10.1111\/head.13407"},{"issue":"11","key":"2418_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0333102416653234","volume":"37","author":"K Makita","year":"2017","unstructured":"Makita K, Inagaki M, Kitamura S, Tatsuoka Y (2017) Changes in migraine before and after menopause in Japanese climacteric women. Cephalalgia 37(11);1088\u20131092. https:\/\/doi.org\/10.1177\/0333102416653234","journal-title":"Cephalalgia"},{"key":"2418_CR26","doi-asserted-by":"publisher","unstructured":"Ng-Mak DS, Headache et al (2011) 51(1);105\u2013117, https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01817.x","DOI":"10.1111\/j.1526-4610.2010.01817.x"},{"issue":"5","key":"2418_CR27","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/01.gme.0000227399.53192.f5","volume":"13","author":"RE Nappi","year":"2006","unstructured":"Nappi RE et al (2006) Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause 13(5):818\u2013825. https:\/\/doi.org\/10.1097\/01.gme.0000227399.53192.f5","journal-title":"Menopause"},{"key":"2418_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2147\/IJWH.S70073","volume":"7","author":"P Ripa","year":"2015","unstructured":"Ripa P et al (2015) Migraine in menopausal women: a systematic review. Int J Womens Health 7:773\u2013782. https:\/\/doi.org\/10.2147\/IJWH.S70073","journal-title":"Int J Womens Health"},{"issue":"5","key":"2418_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.1526-4610.2003.03092.x","volume":"43","author":"SJ Wang","year":"2003","unstructured":"Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH (2003) Migraine prevalence during menopausal transition. Headache 43(5):470\u2013478. https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03092.x","journal-title":"Headache"},{"issue":"2","key":"2418_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.48208\/headachemed.2022.7","volume":"13","author":"G Aykal","year":"2022","unstructured":"Aykal G, Uzun N, Derbent AU, Ye\u011fin A (2022) Assessment of Ovarian Reserve in Patients with Migraine. Headache Med 13(2):117\u2013123. https:\/\/doi.org\/10.48208\/headachemed.2022.7","journal-title":"Headache Med"},{"key":"2418_CR31","doi-asserted-by":"publisher","unstructured":"Carturan P, Scorcine C, Fragoso YD (2016) Migraine in the post-menopausal period is associated with higher levels of mood disorders, disability, and more menopausal symptoms., Arq. Neuropsiquiatr 74(12);999\u20131002. https:\/\/doi.org\/10.1590\/0004-282X20160153","DOI":"10.1590\/0004-282X20160153"},{"issue":"6","key":"2418_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/ana.25476","volume":"85","author":"N Maleki","year":"2019","unstructured":"Maleki N, Cheng YC, Tu Y, Locascio JJ (2019) Longitudinal course of vasomotor symptoms in perimenopausal migraineurs. Ann Neurol 85(6):865\u2013874. https:\/\/doi.org\/10.1002\/ana.25476","journal-title":"Ann Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02418-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:35:52Z","timestamp":1781609752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02418-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2418"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02418-8","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A written informed consent was obtained from all study participants. The study was approved by the Research Ethics Committee (REC) of the Faculty of Medicine, Cairo University (code: MD-450-2023). We assured confidentiality through data anonymization.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We acknowledge that the English text of this manuscript was proofread and corrected using an AI-powered tool (Advanced Grammarly tool)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI tools"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}